Risk assessment and clinical impact of liquid-based cytology, oncogenic human papillomavirus (HPV) DNA and mRNA testing in primary cervical cancer screening (the FASE study). (Q46136299)

From Wikidata

Jump to navigation Jump to search

scientific article published on 9 January 2012

Language	Label	Description	Also known as
English	Risk assessment and clinical impact of liquid-based cytology, oncogenic human papillomavirus (HPV) DNA and mRNA testing in primary cervical cancer screening (the FASE study).	scientific article published on 9 January 2012

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/22233689

Risk assessment and clinical impact of liquid-based cytology, oncogenic human papillomavirus (HPV) DNA and mRNA testing in primary cervical cancer screening (the FASE study). (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/22233689

1 reference

based on heuristic

inferred from title

cervix uterine cancer

1 reference

based on heuristic

inferred from title

Michael Hudgens

2

object named as

Michael G Hudgens

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/22233689

5

object named as

Kari Syrjänen

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/22233689

author name string

Joseph Monsonego

1

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/22233689

Laurent Zerat

3

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/22233689

Jean-Claude Zerat

4

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/22233689

Jennifer S Smith

6

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/22233689

language of work or name

0 references

publication date

9 January 2012

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/22233689

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/22233689

125

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/22233689

1

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/22233689

175-180

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/22233689

Report on consensus conference on cervical cancer screening and management

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Reproducibility of classification and correction for verification bias as determinants of performance of Papanicolaou smear cytology in the screening setting: experience from the New Independent States of the former Soviet Union cohort study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Liquid-based cytology for primary cervical cancer screening: a multi-centre study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Liquid compared with conventional cervical cytology: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Papillomaviruses in the causation of human cancers - a brief historical account

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Long-term follow-up of cervical abnormalities among women screened by HPV testing and cytology-Results from the Hammersmith study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Human papillomavirus testing for cervical cancer screening: results from a 6-year prospective study in rural China

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Evaluation of primary cervical cancer screening with an oncogenic human papillomavirus DNA test and cervical cytologic findings among women who attended family planning clinics in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

How many cervical cancers are prevented by treatment of screen-detected disease in young women?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Age distribution of human papillomavirus infection and cervical neoplasia reflects caveats of cervical screening policies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Value of conventional pap smear, liquid-based cytology, visual inspection and human papillomavirus testing as optional screening tools among latin american women <35 and > or =35 years of age: experience from the Latin American Screening Study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Benefit of cervical screening at different ages: evidence from the UK audit of screening histories

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

PreTect HPV-Proofer: real-time detection and typing of E6/E7 mRNA from carcinogenic human papillomaviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

A cross-sectional study of a prototype carcinogenic human papillomavirus E6/E7 messenger RNA assay for detection of cervical precancer and cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Analytical characterization of the APTIMA HPV Assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Clinical performance of the APTIMA HPV Assay for the detection of high-risk HPV and high-grade cervical lesions

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Comparison of predictors for high-grade cervical intraepithelial neoplasia in women with abnormal smears

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Efficiency of the APTIMA HPV Assay for detection of HPV RNA and DNA targets

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid-based cytology in primary cervical cancer screening: the FASE study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Human papillomavirus genotype specificity of hybrid capture 2

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Modified general primer PCR system for sensitive detection of multiple types of oncogenic human papillomavirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Performance assessment of eight high-throughput PCR assays for viral load quantitation of oncogenic HPV types

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Real-time Taqman PCR targeting 14 human papilloma virus types

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

International terminology of colposcopy: an updated report from the International Federation for Cervical Pathology and Colposcopy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Comparison of human papillomavirus distribution in cytologic subgroups of low-grade squamous intraepithelial lesion

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non-randomized studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Linear array genotyping and hybrid capture II assay in detecting human papillomavirus genotypes in women referred for colposcopy due to abnormal Papanicolaou smear

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2012.01.002

7 January 2021

Identifiers

10.1016/J.YGYNO.2012.01.002

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/22233689

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/22233689

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46136299&oldid=2043307833"